Latest filing published 07 Jan 2014 for DENDREON CORP.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David Urdal: trading record in brief
David Urdal discloses dealings in 2 companies, chiefly Dendreon Corp and Gene Logic Inc. Between 19 January 2006 and 3 January 2014, the trades on record add up to 63 filings.
The open-market side counts 2 purchases for €31k alongside 30 sales for €12.9M. Sales outweigh purchases by €12.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 16 share grants and 15 option exercises.
On 7 January 2014 came the latest disclosure, a share grant in Dendreon Corp. The latest purchase dates back some time: it was published 6,920 days ago, on 28 November 2007. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Urdal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common StockSEC:0001209191-14-002176:0
- 25,000 shares0Common StockSEC:0001181431-13-002095:0
- 25,000 shares0Common StockSEC:0001181431-12-036604:0
- 1,016 shares@ US$10.10Common StockSEC:0001209191-11-052570:0
- 5,313 shares@ US$9.65Common StockSEC:0001209191-11-052144:0
- 2,036 shares@ US$9.65Common StockSEC:0001209191-11-052144:1
- 3,281 shares@ US$4.41Common StockSEC:0001209191-11-043514:0
- 8,754 shares@ US$4.90Common StockSEC:0001209191-11-043514:1
- 1,015 shares@ US$38.75Common StockSEC:0001209191-11-040744:0
- 5,312 shares@ US$39.19Common StockSEC:0001209191-11-039929:0
- 2,035 shares@ US$38.43Common StockSEC:0001209191-11-039929:1
- 1,016 shares@ US$41.04Common StockSEC:0001209191-11-024367:0
- 5,313 shares@ US$42.12Common StockSEC:0001209191-11-023550:0
- 8,898 shares@ US$41.58Common StockSEC:0001209191-11-023550:1
- 2,035 shares@ US$41.68Common StockSEC:0001209191-11-023550:2
- 85,716 shares@ US$35.00Common StockSEC:0001209191-11-020383:0
- 14,026 shares0Common StockSEC:0001209191-11-004747:0
- 1,075 shares@ US$35.05Common StockSEC:0001209191-11-004747:1
- 186 shares@ US$36.90Common StockSEC:0001209191-11-004326:0
- 1,415 shares@ US$36.93Common StockSEC:0001209191-11-003962:0
- 543 shares@ US$36.93Common StockSEC:0001209191-11-003962:1
- 10,000 shares0Common StockSEC:0001209191-10-059505:0
- 4,000 shares@ US$41.61Common StockSEC:0001209191-10-046017:0
- 7,369 shares@ US$40.66Common StockSEC:0001209191-10-045655:0
- 5,000 shares@ US$40.41Common StockSEC:0001209191-10-045655:1
25 of 62 declarations
